| SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis X Shangguan, J He, Z Ma, W Zhang, Y Ji, K Shen, Z Yue, W Li, Z Xin, ... Nature communications 12 (1), 1812, 2021 | 89 | 2021 |
| Glucose limitation activates AMPK coupled SENP1-Sirt3 signalling in mitochondria for T cell memory development J He, X Shangguan, W Zhou, Y Cao, Q Zheng, J Tu, G Hu, Z Liang, ... Nature communications 12 (1), 4371, 2021 | 84 | 2021 |
| Insulinoma-associated protein 1 is a novel sensitive and specific marker for small cell carcinoma of the prostate Z Xin, Y Zhang, Z Jiang, L Zhao, L Fan, Y Wang, S Xie, X Shangguan, ... Human pathology 79, 151-159, 2018 | 67 | 2018 |
| Systemic immune‐inflammation index predicts the combined clinical outcome after sequential therapy with abiraterone and docetaxel for metastatic castration‐resistant prostate … L Fan, R Wang, C Chi, W Cai, Y Zhang, H Qian, X Shao, Y Wang, F Xu, ... The Prostate 78 (4), 250-256, 2018 | 56 | 2018 |
| Prognostic nutritional index predicts initial response to treatment and prognosis in metastatic castration‐resistant prostate cancer patients treated with abiraterone L Fan, X Wang, C Chi, Y Wang, W Cai, X Shao, F Xu, J Pan, Y Zhu, ... The Prostate 77 (12), 1233-1241, 2017 | 39 | 2017 |
| Evaluation of expressed prostatic secretion and serum using surface-enhanced Raman spectroscopy for the noninvasive detection of prostate cancer, a preliminary study X Shao, J Pan, Y Wang, Y Zhu, F Xu, X Shangguan, B Dong, J Sha, ... Nanomedicine: Nanotechnology, Biology and Medicine 13 (3), 1051-1059, 2017 | 39 | 2017 |
| Chromogranin A and neurone‐specific enolase variations during the first 3 months of abiraterone therapy predict outcomes in patients with metastatic castration‐resistant … L Fan, Y Wang, C Chi, J Pan, S Xun, Z Xin, J Hu, L Zhou, B Dong, W Xue BJU international 120 (2), 226-232, 2017 | 36 | 2017 |
| HOXD13 suppresses prostate cancer metastasis and BMP4‐induced epithelial‐mesenchymal transition by inhibiting SMAD1 F Xu, X Shangguan, J Pan, Z Yue, K Shen, Y Ji, W Zhang, Y Zhu, J Sha, ... International journal of cancer 148 (12), 3060-3070, 2021 | 35 | 2021 |
| Albumin and fibrinogen combined prognostic grade predicts prognosis of patients with prostate cancer Y Wang, W Chen, C Hu, X Wen, J Pan, F Xu, Y Zhu, X Shao, ... Journal of Cancer 8 (19), 3992, 2017 | 30 | 2017 |
| Squalene epoxidase metabolic dependency is a targetable vulnerability in castration-resistant prostate cancer X Shangguan, Z Ma, M Yu, J Ding, W Xue, J Qi Cancer Research 82 (17), 3032-3044, 2022 | 27 | 2022 |
| Influence of abiraterone acetate on neuroendocrine differentiation in chemotherapy‐naive metastatic castration‐resistant prostate cancer B Dong, L Fan, Y Wang, C Chi, X Ma, R Wang, W Cai, X Shao, J Pan, ... The Prostate 77 (13), 1373-1380, 2017 | 25 | 2017 |
| Serum pre-albumin predicts the clinical outcome in metastatic castration-resistant prostate cancer patients treated with abiraterone L Fan, C Chi, S Guo, Y Wang, W Cai, X Shao, F Xu, J Pan, Y Zhu, ... Journal of Cancer 8 (17), 3448, 2017 | 18 | 2017 |
| Downregulation of SHMT2 promotes the prostate cancer proliferation and metastasis by inducing epithelial-mesenchymal transition L Chen, H Liu, Y Ji, Z Ma, K Shen, X Shangguan, H Qian, Y Zhao, ... Experimental cell research 415 (2), 113138, 2022 | 13 | 2022 |
| Abiraterone acetate for chemotherapy-naive metastatic castration-resistant prostate cancer: a single-centre prospective study of efficacy, safety, and prognostic factors L Fan, B Dong, C Chi, Y Wang, Y Gong, J Sha, J Pan, X Shangguan, ... BMC urology 18, 1-8, 2018 | 9 | 2018 |
| Cell cycle progression score improves risk stratification in prostate cancer patients with adverse pathology after radical prostatectomy X Shangguan, H Qian, Z Jiang, Z Xin, J Pan, B Dong, W Xue Journal of Cancer Research and Clinical Oncology 146, 687-694, 2020 | 8 | 2020 |
| Management of prostate cancer patients with locally adverse pathologic features after radical prostatectomy: feasibility of active surveillance for cases with Gleason grade 3+ 4= 7 X Shangguan, B Dong, Y Wang, F Xu, X Shao, J Sha, Y Zhu, J Pan, ... Journal of cancer research and clinical oncology 143, 123-129, 2017 | 7 | 2017 |
| Prostate transitional zone volume-based nomogram for predicting prostate cancer and high progression prostate cancer in a real-world population Y Wang, S Xie, X Shangguan, J Pan, Y Zhu, Z Xin, F Xu, X Shao, L Fan, ... Journal of cancer research and clinical oncology 143, 1157-1166, 2017 | 5 | 2017 |
| Immune infiltration phenotypes of prostate adenocarcinoma and their clinical implications Z Ma, X Cheng, T Yue, X Shangguan, Z Xin, W Zhang, J Pan, Q Wang, ... Cancer Medicine 10 (15), 5358-5374, 2021 | 3 | 2021 |
| Serum levels of neuroendocrine differentiation markers predict the prognosis of patients with metastatic castration resistant prostate cancer treated with abiraterone acetate L Fan, B Dong, C Chi, X Shao, J Pan, Y Zhu, Y Wang, W Cai, H Qian, ... Chinese Journal of Urology, 362-366, 2018 | 1 | 2018 |
| PROGNOSTIC VALUE OF CELL CYCLE PROGRESSION SCORE IN PROSTATE CANCER PATIENTS WITH LOCALLY ADVERSE PATHOLOGY AFTER RADICAL PROSTATECTOMY: IMPLICATIONS FOR TREATMENT GUIDANCE … X Shangguan, W Xue, B Dong, J Pan, H Qian, F Xu Journal of Urology 199 (4), e818, 2018 | | 2018 |
